Caribbean have been examined on shipboard for a variety of bioactlvities and their constituents studied there by gas chromatography! mass spectrometry. A very high proportion of the extracts has been shown to be cytotoxic, a high proportion to be antibacterial or antifungal and a surprisingly large number to be antiviral. Many of these activities have been confirmed in more extensive assays against tumor cells, pathogenic microorganisms and a battery of viruses. A number of the compounds responsible for the activities have been identified, including several new compounds. Of special current interest are the didemnins, depsipeptides isolated from a didemnid tunicate, which inhibit a number of RNA and DNA viruses and exhibit potent cytotoxicity vs. tumor cell lines.
mass spectrometry. A very high proportion of the extracts has been shown to be cytotoxic, a high proportion to be antibacterial or antifungal and a surprisingly large number to be antiviral. Many of these activities have been confirmed in more extensive assays against tumor cells, pathogenic microorganisms and a battery of viruses. A number of the compounds responsible for the activities have been identified, including several new compounds. Of special current interest are the didemnins, depsipeptides isolated from a didemnid tunicate, which inhibit a number of RNA and DNA viruses and exhibit potent cytotoxicity vs. tumor cell lines.
Systematic studies of marine natural products can be directed toward a particular phylum, such as sponges (Ref. 1) , toward a particular class of compounds, such as sterols (Ref. 2) , toward a class of compounds in a phylum, such as terpenes in gorgonians (Ref. 3) , or toward a particular bioactivity, such as antineoplastic activity (Ref. 4) . Our own interest in marine natural products arose initially out of our continuing studies on antibiotics (Ref. 5) , and has been directed toward compounds possessing antimicrobial (antibacterial or antifungal) or, more recently, antiviral or antineoplastic activity. In the first instance, we sought to determine whether such activities are widely distributed among the marine phyla and, in the second instance, to ascertain whether the compounds responsible for the activities are of novel Or useful structural types.
The primary collecting of marine species for examination was carried out during two expeditions (in 1974 and 1978) aboard the R/V Alpha Helix, a research vessel with laboratory space designed for marine biology and biochemistry studies and sponsored by the U.S. National Science Foundation. During each of these expeditions a comprehensive survey of specific bioactivities was carried out on shipboard, with assays designed to use small samples of the marine species (to avoid ecological disruption) on site (to allow recollection of species with significant activity). The first of these expeditions (AHBE 1974 ) examined the antimicrobial activities of some 831 species along the west coast of Baja California and in the *This paper is dedicated to the memory of Werner Bergmann, a pioneer in studies of marine natural products and an inspiring teacher of Yale students.
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Gulf of California, which separates the west coast of the Mexican mainland from the Baja California peninsula, at sites selected to include a variety of climatic zones (Ref. 6, 7) . To speed the identification of antimicrobial compounds in the extracts, a gas chromatographic mass spectrometer was employed on the Alpha Helix (Ref. 8 ). These antimicrobial results, which have been reported in brief elsewhere(i&i. 7) and are repeated here in Table 1 , showed that antimicrobial activity can be found in a number of phyla and is particularly prominent in the Porifera and the Echinodermata. The extracts from AHBE 1974 Table 2 . Although non-systematic, the latter assays did indicate occasional antiviral activity and widespread cytotoxicity in marine extracts and these indications led to our incorporating systematic antiviral and cytotoxicity assays into our second expedition, as described in the next paragraph. From time to time, additional samples of active species identified from the AHBE 1974 collection have been collected, as necessary, in Baja California (Ref. 10) , employing a mobile laboratory consisting of a converted 26-foot GMC motor home equipped with chromatographic and other scientific equipment and collecting equipment (16-foot Boston Whaler, 85-horsepower outboard engine, scuba tanks, compressor, etc.).
The second expedition (AHCE 1978) explore.d Caribbean fauna and flora with similar goals. In this case, the ship's track commenced in Panama and the R/VAlpha Helix visited collecting sites in Panama, Colombia, Nicaragua, Honduras, Belize and Mexico (Figure 1 ). To the bloassays previously employed on the ship vs. the four microorganisms cited in Table 1 was added a screen for inhibition of a Herpes virus in monkey kidney cells (CV-l). The latter indicated not only antiviral activity but also cytotoxicity, which might predict antineoplastic activity. These results are summarized in Table 3 . A shipboard assay was also carried out for stimulation of acetylcholine release by fish brain synaptosomes (Ref. 11). Table 3 shows again that the Porifera provide a rich source of antimicrobial activity. The larger number and proportion of sponge samples from AHCE 1978 relative to AHBE 1974 reflect in part the differing abundance of sponges in Caribbean vis-a-vis Baja California waters and in part a preferential collection of those phyla shown previously to provide likely sources of bioactive compounds.
Although the incidence of antimicrobial activity was quite high in the Porifera and Echinodermata, it was also above 25% in the Chordata, Cnidaria and the four major marine plant phyla. Moreover, antiviral activity was highest in the Cyanophyta, Phaeophyta and Chordata Antiviral, antimicrobial, and antineoplastic agents 797 
(10) Microbial, viral and cell line abbreviations same as for Tables 1 and 2 .
Number of species examined same as overall antimicrobial except as noted.
(Ascidiacea). We had earlier observed modestantiviral activity in other compound tunicates (Ref. 12, 13) ; thus, the latter observation came as no surprise. Cytotoxicity was widely distributed among the phyla.
With the large number of active organisms shown in Tables 1-3 and a limited number of coworkers, it was necessary to arrange the active species in an order of priority according to some pre-considered quantitative measure of activity. This measure would then guide the studies toward the most interesting compounds, at least from a biological standpoint, the chemical standpoint being, in any event, unpredictable. For the AHBE organisms these priority lists are shown in Tables 4-7 for activities against Escherichia coli, Bacillus us, Saccharomyces cerevisiae, Penicillium atrovenetum, Herpes sirplexvirus,type I, and L12l0 or KB cells. Tables 4 and 5 derive, as noted above, from comprehensive on-site testing of essentially all the AHBE samples, Tables 6 and 7 from far more limited, and later, testing. The four tables indicate that while the highest incidence of activity may be in the Porifera and the Echinodermata (cf. Tables 4-7 , a number have yielded compounds reported previously by our group or by groups elsewhere (Fig. 2, 3 We have comented elsewhere (Ref. 29) regarding the rather vague use of the term 'antibiotic' for compounds from marine sources having antibacterial properties and shall return to that theme later in this report. Suffice it here to state that, where the actual minimum inhibitory concentrations (MIC's) are known for compounds they are generally large, too large to suggest clinical potential.
In the present report we shall concentrate our attention on the systematic studies carried out during and following our more recent Alpha Helix Expedition (AHCE 1978) . Here again, the most active samples were initially arranged, as in Tables 8-13 , in a priority order of their activities determined on shipboard. In this case first priority was assigned to activity against a Herpes virus, followed by activity against E. coil, P. atrovenetum, S. cerevisiae and B. subtilis, and finally cytotoxicity against monkey kidney cells. The most active shipboard samples were then re-tested at The Upjohn Company--anti-res samples against a variety of viruses, antimicrobial samples against a broad spectrum of microorganisms including pathogens, cytotoxic samplesagainst L12l0 (leukemia) cells. This second level of screening was designed to winnow the samples to those which might have some hope of clinical candidacy. A striking feature of some of the Tables (8, 9 ) is the number of extracts active on shipboard which were found to be inactive in the secondary, pharmaceutical screens. Although this may reflect, in part, the use of less sensitive microorganisms or different cell lines, the principal reasons for the lack of activity are felt to be the generally lower concentrations of the samples employed in the secondary screens and the decomposition of many of the active compounds during storage (even, in some cases, in frozen samples of marine species). Thus, the secondary screen tended to select for stable compounds active at low concentrations. One heartening aspect of the secondary screening was a general correlation between cytotoxicity toward monkey kidney cells and Ll2lO cells (Table 13 ).
The remaining sections of the paper will discuss results obtained with some of the more active extracts passing the second level of examination in Tables 8-13 . Table 4 . bUpjohn screen; + = active against one or more viruses at 1 mg/mL. cNT = not tested. An example of the shipboard extracts most active in i.nhibiting the growth of CV-l (monkey kidney) cells (Table 13) was that from the gorgonian AHCE #150 (Pseudoplexaura flaellosa). Secondary screening of the extract against L12l0 leukemia cells showed it to have ID50 0.35 pg/mL, also placing it among the most L1210-inhibitory extracts. Field desorption mass spectrometry (FOIlS) of the extract indicated its major component to have the molecular weight 376 and isolation of this major component by trituration with acetone, chromatography over silica gel and crysallizajon yielded a compound with the molecular formula C22H3205 (mol wt 376.2239). The 'H and "C NMR spectra of the isolated compound showed the The Caribbean red alga Laurencia intricata provided some of the most active extracts assayed on shipboard against Bacillus subtilis (Table 12 , AHCE #1060; cf. also Table 14 ). Gas chromatography/mass spectrometry (C7ftS1f this and other extracts of L. intricata (AHCE #1060, 1165, 1227 and 1244, Table 14) showed the presence of a single major component, together with a number of minor components, whether the sample was collected in Colombian, Honduran, Belizean or Panamanian waters. The similarity of the GC traces confirmed the utility of GC (even on shipboard) as a promising tool for chemotaxonomy of Laurencia species, as indicated in our earlier papers (Ref. 17, 18) .
The major component of L. intricata satisfied all the criteria advanced earlier (Ref. 17, 18) for its identity with isolaurinterol (, Scheme 1): the molecular ion appeared at rn/z 294 and contained one bromine atom, the compound formed an acetate, hence contained a hydroxyl group, and it did not give the ion due to loss of C5H8 (M -68 at rn/z 226) characteristic of laurinterol (n).
We have recently investigated the use of methylene unit values (Ref. 31 ), comparing retention times to those of a series of alkanes, as an aid to characterizing marine metabolites in the field (Ref. 32) . This procedure has the advantage of being more reproducible than the simple retention times previously employed by us (Ref. 8, 17) and does not require such elaborate instrumentation as GC/MS. In any event, isolaurinterol has MU = 19.0 (Table 15 ). The major component of L. intricata, however, has MU = 19.9 and, thus, cannot be isolaurinterol. Accordingly, the major component of L. intricata sample AHCE #1227 was isolated by chromatography over a silic gel column followed by preparative thinlayer chromatography on a silica gel plate. The 'H NMR spectrum of the isolated compound's acetate was compared with that reported for isolaurinterol acetate (u), which confirmed that indeed a different material was present in L. intricata. On the other hand, the general overall similarity of the spectra suggested a closely related compound and a comparison with literature properties revealed the identity of the 1H NMR spectrum of the acetate of the compound from L. intricata with that reported for allolaurinterol acetate (), the derivative of allolaurinterol (), previously isolated from Laurencia filiformis forma heteroclada (Ref. 33) . Allolaurinterol was reported to undergo prototropic rearrangement to a cyclic ether, filiformin (4) (Ref. 33) , in the same way that isolaurinterol (j) undergoes rearrangement to aplysin (, Scheme 1) (Ref. 34 ). The material from L. intricata Another Laurencia species, Laurencia obtusa, also provided several of the most active extracts in inhibiting Bacillus subtilis on shipboard (Table 12 , AHCE #1058, 1028, 1027, 1211; cf. also Table 14 ). In addition, severT of the samples showed strong cytotoxicity toward CV-l cells (Table 13 , AHCE #1020, 1028; cf. also Table 14 ). In the case of L. obtusa, several forms were identified (Table 14) , perhaps corresponding to subspecies. Lack of homogeneity of the species was also indicated by the Table 9 ). cMU = methylene unit value of most abundant component in GC trace. (Table 14) and by the differing gas chromatographic traces of L. obtusa extracts. The correspondence between forms judged morphologically identical and those judged the same by their GC traces was by no means perfect, but in general the gas chromatographic trace for AHCE #1027 was typical of L. obtusa Forms I (AHCE #1026, 1027, 1068, 1120, 1128), II (AHCE #1028, 1100, 1121, 1170) anVIII (AHCE #1058). Forms V and VII gave different traces (as did some of the samples originally assigned to Forms I, II and VIII, Table 14 ). The characteristic .GC pattern for Forms I, II and VIII was one containing a single major constituent (MU 21.2) whose molecular weight was 332 and which was easily demonstrated to contain one bromine atom and one chlorine atom by the isotope peak pattern for the molecular ion. Thus, the typical gas chromatogram of L. obtusa is dominated by a compound quite different from allolaurinterol. The compoundQf molecular weight 332 was accordingly isolated by chromatography over silica gel. The 'H NMR spectrum indicated clearly a compound containing two quaternarymethyl groups (l.07s, l.08s) and one vinyl methyl group (l.70m).
In this case, comparison with known compounds revealed the previous isolation from L. elata (Ref. 35 ) and later from L. obtusa from the Atlantic zone (Ref. 36 ) of a compound with similar properties--elatol (). Closer comparison of the 1H NMR spectrum of the material isolated from the Caribbean L. obtusa with that reported for elatol confirmed the identity of the two. However, our sample of elatol has the opposite rotation and, thus, the opposite absolute configuration from the previously described elatol (Ref. 35, 36) .
There was a generally close correspondence between the degree of inhibition of gram-positive bacteria (B. subtilis, Table 14 ) and the amount of elatol in the alga as judged by GC traces. On the other hand, there was little correlation of extracts of L. obtusa between activity against B. subtilis and cytotoxicity toward CV-l cells. Thus, cytotoxicity did not correlate well with the presence of elatol ( We turn now from red algae to sponges collected during AHCE 1978. A rich source of marine antibacterial compounds in the past has been the genus Aplysina. In Tables 9 and 12 several of the most active extracts vs. E. coli and B. subtilis are from Aplysina samples or related genera and some of these havrbeen investigated. For example, a sample of A. fistularis (AHCE #527), represented in Table 9 by AHCE #64, gave , previously isolated iWiur labora- (Tables 12 and 9 ) and the pattern of activities (B. subtilis > E. coli, no antifungal activity, modest cytotoxicity, Table 16 ) of these and a number of other samples classified as these two p]ysina species or as Smenosppngja aurea was similar. Although three sponge species were ostensibly represented, GC/MS of the sponge extracts showed most of the samples to contain one or more of three components--two closely related compounds containing bromine and a third compound lacking halogen (Table 16 ). The extract from sponge #583 was separated by acid extraction into basic and neutral components. On the basis of GC/HREIMS of the basic material the two bromine containing compounds were identified as mono-and dibromo-N,N-dimethyltryptamines ( and , respectively).
From our earlier work with brominated indoles (3J-,3) from Laurencia brongniartii (Ref. 44) we anticipated the bromines in the dibromoindole derivative would be at C-S and C-6 () and that the single bromine in the monobromoindole should be at C-S (as in ) or C-6. The 'H NMR spectrum (CD3COCD3) of a 2: The molecular formula of the halogen-free compound was indicated by gas chromatography/high resolution electron, impact mass spectrometry (GC/HREIMS) to be C21H3003 (314.2243) and the characteristic peaks at rn/z 191.1791 (C14H23) and rn/z 123.0455 (C7H702) in1icated it to have the structure of a sesquiterpene-substituted hydroquinone (Ref. 26) . The H NMR spectrum of the isolated C21 compound [O.78s (3H), O.92s (3H), l.06s (3H), l.lld (3H)] argued for a structure closely related to that of zonarol, though the skeleton appeared to be slightly rearranged, judging from the number of methyl groups present. While we were in the process of isolating an adequate sample of the sesquiterpenic hydroquinone for structural elucidation, the same compound and also the brominated dimethyltryptamines were reported from Smenospongia aurea and S. echina by the Faulkner group (Ref. 45 ) and the structures assigned as , and ,3 (aureol), with aureol containing a rearranged zonarol structure as determined by X-ray cr'stallography.a Identity of melting point, rotation and spectral properties (especially 3C NMR signals) assures the identity of our sesquiterpene-substituted hydroquinone with aureol.
Before leaving the subject of sponges we should note the utility of the antimicrobial spectrum of an extract in characterizingthe compounds present. As an example, from the AHCE collection a number of sponges were identified as having interesting antimicrobial activity (Table 17 ). The sponges were initially identified on shipboard as belonging to several species or not identified at all. However, when they were subjected to the secondary screen the broad antimicrobial spectrum shown for the extracts (Table 17 ) was so comparable (B. subtilis > B. fragilis > K. pneumoniae> M. avium > S. lutea > S. aurea, etc.) that it seemed likely that the compounds present might well be similar or the same. Indeed, preliminary chemical examination of the sponge extracts by FDMS indicated the occurrence of a number of the same molecular ions in all three groups of sponge samples. Although the sponge species are still not certain, the compounds present appear for the most part to be the same. The structures of the 34 AUREOL compounds will be discussed elsewhere, but the utility of a broad antimicrobial screen in relating compounds is evident. However, even these compounds, derived from one of our most potent extracts, were not sufficiently active against pathogens to warrant further investigation as antibacterial agents. One of them, for example, had a MIC of 25 tg/mL vs. Streptococcus pypgenes, an MIC of 100 pg/mL vs.
S. pneumoniae and Staphylococcus aureus, and MICs > 100 g/mL vs. 29 other bacteria. Most marine antibacterial agents simplydo not compare favorably with classical antibiotics derived from terrestrial microorganisms.
The final compounds for discussion are a group of peptides derived from a Caribbean tunicate, an as yet unidentified member of the family Didemnidae, probably a Didemnum species. Extracts of this tunicate were already observed on shipboard to inhibit Herpes virus (Table  8 , AHCE #55) and to exhibit potent toxicity to monkey kidney cells (Table 13 , AHCE #755). The antiviral activity was subsequently confirmed in the secondary screens against not only Herpes simplex virus (types I and II) but against another DNA virus (vaccinia virus), as well as against a number of RNA viruses--influenza (PR8), parainfluenza-3 (HA-l), Coxsackie A-2l (COE) and equine rhinovirus (E.R.)--as seen in Table 18 . Antiviral activity in the ait is somewhat amusing to note that the time employed for identification of the compounds in both laboratories appears to have been approximately two years, the Faulkner group having visited the Caribbean on the Alpha Helix in September 1977 and our own group in February 1978, and more amusing to note that our Caribbean expedition on the Alpha Helix was originally scheduled for September 1977, but was delayed by the grant review process. .T. Company screen at 1 mg/mL. cSee footnotes, Table 9 .
tunicate extract was followed through the purification shown in Scheme 2. The compounds isolated, didemnins A, B and C, have the activity profiles shown in Table 19 , which shows all three compounds to have antiviral activity and cytotoxicity. Didemnin A appears to be especially promising as an antiviral agent and didemnin B to be highly cytotoxic to L1210 cells, thus a potentially useful antitumor agent. Didemnin C, obtained in small quantities, is also antiviral. Each of the three didemnins is a mixture of homologs. The molecular Table 18 .
weights of the major components of didemnins A, B and C were established by FOMS as 942, 1111, and 1014, respectively. Didemnin A was chosen for initial study due to its lower molecular weight. Didemnin A was first suspected to be a peptide from the three NH protons near 8 ppm in its 1H NMR spectrum. Recognition of its peptide nature allowed application of a procedure for structure assignment of peptides recently developed in our laboratory and highly dependent on advanced mass spectrometric techniques (Ref. 5c). Hydrolysis of the peptide gave a mixture of amino acids (Scheme 3), which was analyzed by FDMS, identifying molecular ions. The amino acids were also derivatized with trifluoroacetic anhydride and n-butyl alcohol and analyzed by GC/MS. The latter technique identified leucine (Leu), threonine (Thr) and proline (Pro), identifications confirmed by co-injection of derivatized authentic samples of those three amino acids and by identification in an amino acid analyzer. Three other amino acids were also identified by GC/MS in the hydrolyzate. N-Methylleucine (MeLeu) was suspecteçt from the similar fragmentation of its derivative to that of Leu and the presence in the 'H NMR spectrum of didemnin A of two (non-acylated) N-methyl singlets (at 2.4 and 2.6 ppm). Co-injection of an authentic sample of derivatizd MeLeu confirmed the identification of the amino acid. The second N-methyl peak in the 'H NMR spectrum and an aromatic 0-methyl peak (3.8 ppm) were believed to be associated with a compound giving a molecular ion at rn/z 361 in its derivative's GC/chemical ionization (CI) mass spectrum (Scheme 4) as well as an intense peak at rn/z 121 (C8H9O). The amino acid was assigned from these observations as N,0-dimethyltyrosine Me2Tyr) and the assignment was confirmed by comparison with an authentic sample (Ref. 46) , including co-injection of its derivative on GC.
The two remaining peaks in the gas chromatogram could both be ascribed to the same CH17N03 amino acid, one GC peak representing the N,0-bis(trifluoroacetyl) derivative of the butyl ester, the other GC peak representing the compound resulting from loss of trifluoroacetic acid from the bis(trifluoroacetyl) derivative. In its mass spectrum the N,0-bis(trifluoroacetyl) derivative loses trifluoroacetic acid and also shows an intense fragment ion for C5H12NCOCF3 (Scheme 4). Among compounds with the formula C8H17NO3, the hydroxy amino acid statine, 4-amino-3-hydroxy-6-methylheptanoic acid (Sta), isolated from pepstatin (Ref. If one adds together the molecular formulas assignable to the six aminoacyl units--Leu, Pro, Thr, MeLeu, Me2Tyr, and Sta--the partial formula C41H66N609 is obtained. HRFDMS and HREIMS carried out on didemnin A gave the value 942.5678 for the molecular ion, and if the accurate mass (786.4891) corresponding to the partial formula C41H66N609 is subtracted from that, the residue 156.0787 corresponds best to the formula C8H1203 (156.0786). Indeed, the FD mass spectra of basic and partial acid hydrolyzates of didemnin A (see below) both contained ions for C8H1203 (e.g., 156.0794).
Treatment of didemnin A with acetic anhydride gave a diacetyl derivative (M = 1026; COCH3, The structure for didemnin B follows directly from that for A, since the HRFDMS molecular ion for didemnin B (1112.6442, C57HgN7Oj5, M + H) indicates an additional CçH1jNO3 not found in didemnin A. Acidic hydrolysis of didemnin B gives one extra mole o1 Iro, accounting for C4H7NO. The MeLeu and the extra Pro unit can be shown to be acylated from the 1H NMR spectrum, which also identifies the remaining C3H402 as a lactyl, CH3çH_CO-. group. OH Thus, the structure of didemnin B is ,. Didemnin C (1014.5873, Cç2H82N6O14, HRFDMS) contains an acylated MeLeu unit and is assigned structure 3. With tFieir potent antiviral and cytotoxic activities and their easily modifiable structures, the didemnins offer considerable therapeutic promise.a All three didemnins contain as minor components homologs, with norstatine (4-amino-3-hydroxy-6-methylhexanoic acid) replacing statine. The occurrence of this amino acid is of special interest, since it is presumably derived biosynthetically from valine and acetate. Its biosynthesis may, thus, be related to that of Hip.
One of the hopes for success of marine natural products research is that the compounds' structures identified will be sufficiently simple that they can be synthesized for testing in vivo, either in their own right or in an analog program. Such an analog program has Tready been initiated for study of the earlier reported acarnidines (Ref. 50 ) and polyandrocarpidines (Ref. 51 ). The didemnins, relatively simple peptides with antiviral and cytotoxic properties, are, as noted above, exceedingly tempting targets for synthesis and modification by synthesis. Whether or not any of the compounds described in the present report prove ultimately useful in clinical studies, we feel that some of the materials have sufficient promise to establish the validity of our systematic approach toward the study of biologically active compounds from marine sources.
During the course of the research a surprising number of biological and chemical techniques were shown to be systematically feasible on shipboard, including antimicrobial, antiviral, and cytotoxicity assays, gas chromatography and gas chromatography/mass spectrometry (by our group), haloperoxidase and organic halogen assays (by Dr. L. P. Hager's group), and acetylcholine release assays (by Dr. W. 0. McClure's group). Of course, such a systematic approach would not have been possible without the availability of the R/V Alpha Helix.b In that context, it is regrettable that this type of highly fruitful study of biologically active compounds in marine species can apparently never be repeated. The National Science Foundation's Ships Board, in early 1980, removed the R/VAlpha Helix from service as the only NSF vessel directed primarily toward studies of marine biology, and transferred it to the pool of NSF vessels engaged primarily in studying oceanography. aFootnote added in proof. We have recently revised the sequence shown for didemnins A, B and C to +Leu+Pro+Me2Tyr+ rather than the reverse. Thus, are R-41eLeu÷ThrStaHi p4LeuPro-'+Ie2Tyr -1 Also, the tunicate has recently been tentatively identified as a Trididemnum species. bOne prominent reviewer of our AHBE 1974 proposal argued that everything we proposed to do on that expedition could be better done from a shore station.
